MR

Michael Rützler

CEO at ApoGlyx

No bio yet


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


ApoGlyx

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.


Industries

Links